TIMOTHY STREET: Open Payments
NPI 1285635136 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 20 payments from 11 companies in 2025. Trend: 2023 $1,038 · 2024 $640 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $158 |
| ABBVIE INC. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Verona Pharma, Inc. | 1 | $33 |
| GENZYME CORPORATION | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: FARXIGA, Kerendia, VRAYLAR, Ohtuvayre, UBRELVY, FABRAZYME, AUSTEDO XR, BEYFORTUS.
Industry payments across MT — which companies pay providers there.
